Holen Sie sich die Stockscreener-App
2.13
12.96%
-0.30
Schlusskurs vom Vortag:
$2.43
Offen:
$2.43
24-Stunden-Volumen:
113.91K
Relative Volume:
0.72
Marktkapitalisierung:
$39.97M
Einnahmen:
$420.00K
Nettoeinkommen (Verlust:
$-26.98M
KGV:
-0.5105
EPS:
-4.1721
Netto-Cashflow:
$-32.01M
1W Leistung:
-16.40%
1M Leistung:
-68.92%
6M Leistung:
-95.35%
1J Leistung:
-98.95%
1-Tages-Spanne:
$2.10
$2.43
1-Wochen-Bereich:
$2.10
$2.88
52-Wochen-Spanne:
$2.10
$1,030.00
Kala Bio Inc Stock (KALA) Company Profile
Firmenname
Kala Bio Inc
Sektor
Branche
Telefon
781-996-5252
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
2.15 | 45.17M | 420.00K | -26.98M | -32.01M | -4.1721 |
VRTX
Vertex Pharmaceuticals Inc
|
436.69 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.59 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.19 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.62 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.32 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Eingeleitet | Mizuho | Outperform |
| 2025-07-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-07-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-05-27 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Kala Bio Inc Aktie (KALA) Neueste Nachrichten
KALA Should I Buy - Intellectia AI
Kala Bio (FRA:27F) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2026) - GuruFocus
Red Light Holland Corp (OP: TRUFF - FinancialContent
KALA stock hits record low – firm announces reverse split after shares fail to surpass the $1 mark - MSN
KALA BIO (KALA) files 13G/A: Baker Bros. reports 2,312 shares post-split - Stock Titan
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q Summary - TradingView
KALA BIO: Q1 Earnings Snapshot - kare11.com
KALA: Q1 2026 net loss fell to $1.6M as focus shifted to AI platform and cost reductions - TradingView
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
KALA BIO (NASDAQ: KALA) slashes R&D spend and pivots to Researgency AI platform - Stock Titan
Exclusive: Penny stock Kala Bio transitions to revenue model with AI platform launch - MSN
Total assets of KALA BIO, Inc. – LSX:A4243T - TradingView
Discontinued operations of KALA BIO, Inc. – TRADEGATE:27F - TradingView
Cash from operating activities of KALA BIO, Inc. – FWB:27F - TradingView
Asset turnover of KALA BIO, Inc. – FWB:27F - TradingView
Working capital per share of KALA BIO, Inc. – FWB:27F - TradingView
Price to book ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Balance Sheet – TRADEGATE:27F - TradingView
Discontinued operations of KALA BIO, Inc. – LSX:A4243T - TradingView
Dilution adjustment of KALA BIO, Inc. – GETTEX:27F - TradingView
KALA BIO, Inc. Balance Sheet – LS:A4243T - TradingView
KALA BIO, Inc. Balance Sheet – GETTEX:27F - TradingView
Discontinued operations of KALA BIO, Inc. – FWB:27F - TradingView
Enterprise value to EBITDA ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Earnings and Revenue – MUN:27F - TradingView
Why Kala Bio’s Stock Is Sinking Again - TipRanks
CapEx per share of KALA BIO INC. O.N. – MUN:27F - TradingView
EBIT per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Free cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Long term debt to total equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
Tangible book value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Debt to equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Net current asset value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Total debt per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Inventory turnover of KALA BIO INC. O.N. – MUN:27F - TradingView
Operating cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Cash per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Working capital per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Revenue per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Price to cash flow ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Gross margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Cost of goods sold of KALA BIO INC. O.N. – MUN:27F - TradingView
Non-controlling/minority interest of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted earnings per share (diluted EPS) of KALA BIO INC. O.N. – MUN:27F - TradingView
Average basic shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Taxes of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Discontinued operations of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted net income available to common stockholders of KALA BIO INC. O.N. – MUN:27F - TradingView
Finanzdaten der Kala Bio Inc-Aktie (KALA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):